AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇸🇳
MIDAZOLAM in Senegal
6 products registered with ARP — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MEVIROX solution injectable / 5 mg | UNKNOWN-1a2c140a | IPNODIS MEDIS | active | — |
| MIDAZOLAM BIOTIS PHARMA comprimé / 2% | 5656 | BIOTIS PHARMA | active | — |
| MIDAZOLAM BIOTIS PHARMA ampoule injectable / 5mg / ml | 5654 | BIOTIS PHARMA | active | — |
| IPNODIS MEDIS solution injectable / 5 mg | UNKNOWN-97d863ea | MEDIS | active | — |
| MEVIROX solution injectable / 5 mg | UNKNOWN-09e8bb6b | IPNODIS MEDIS | active | — |
| IPNODIS MEDIS solution injectable / 5 mg | UNKNOWN-d90f94c5 | MEDIS | active | — |
MIDAZOLAM — ARP Registration Details
ARP (Senegal) has 6 registered products containing MIDAZOLAM, of which 6 are currently active. Data is sourced directly from the official ARP drug register and refreshed daily.
Track MIDAZOLAM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.